With its versatile and powerful TEMPO epigenomic control platform, Tune Therapeutics is pioneering a new therapeutic modality that can fine-tune any gene network and unlock the full power and potential of regenerative medicine.

With deep experience and a passionate commitment to exploration and innovation, Tune is driving through an inflection point in the history of genetic medicine: from targeting a limited range of rare conditions, to addressing thousands of common and complex diseases for which no curative treatment is available.

Biotechnology

Education

Tune Therapeutics

The Seattle office focuses on advancing quality, research, and intellectual property in the biotechnology and pharmaceutical sectors.

Seattle

Tune Therapeutics' headquarters in Durham, NC, United States

People (25)

Jobs (0)

Other offices